Manalo, Babyn A.

HRN: 13-90-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/15/2022
CEFUROXIME 1.5GM (VIAL)
07/15/2022
07/15/2022
IV
1.5 Grams
Loading Dose
STAT REPEAT CS
Waiting Final Action 
07/15/2022
CEFUROXIME 1.5GM (VIAL)
07/15/2022
07/22/2022
IV
1.5g
Q8
LTCS
Waiting Final Action 
07/15/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/15/2022
07/15/2022
IV
1G
Now
Thickly MSAF
Waiting Final Action 
07/16/2022
CEFUROXIME 500MG (TAB)
07/16/2022
07/23/2022
ORAL
500mg
BID
S/P CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: